» Articles » PMID: 36798514

Antimicrobial Susceptibility of Bacterial Isolates from Clinical Specimens in Four Pacific Island Countries, 2017-2021

Abstract

Background: There are limited antimicrobial resistance (AMR) surveillance data from low- and middle-income countries, especially from the Pacific Islands region. AMR surveillance data is essential to inform strategies for AMR pathogen control.

Methods: We performed a retrospective analysis of antimicrobial susceptibility results from the national microbiology laboratories of four Pacific Island countries - the Cook Islands, Kiribati, Samoa and Tonga - between 2017 and 2021. We focused on four bacteria that have been identified as 'Priority Pathogens' by the World Health Organization: and

Findings: Following deduplication, a total of 20,902 bacterial isolates was included in the analysis. The most common organism was (n = 8455) followed by (n = 7830), (n = 2689) and (n = 1928). The prevalence of methicillin resistance among isolates varied between countries, ranging from 8% to 26% in the Cook Islands and Kiribati, to 43% in both Samoa and Tonga. Ceftriaxone susceptibility remained high to moderate among (87%-94%) and (72%-90%), whereas amoxicillin + clavulanate susceptibility was low against these two organisms (50%-54% and 43%-61%, respectively). High susceptibility was observed for all anti-pseudomonal agents (83%-99%).

Interpretation: Despite challenges, these Pacific Island laboratories were able to conduct AMR surveillance. These data provide valuable contemporary estimates of AMR prevalence, which will inform local antibiotic formularies, treatment guidelines, and national priorities for AMR policy.

Funding: Supported by the National Health and Medical Research Council.

Citing Articles

Successful management of a multi-species outbreak of carbapenem-resistant organisms in Fiji: a prospective genomics-enhanced investigation and response.

Young-Sharma T, Lane C, James R, Wilmot M, Autar S, Hui K Lancet Reg Health West Pac. 2024; 53:101234.

PMID: 39633714 PMC: 11616059. DOI: 10.1016/j.lanwpc.2024.101234.


Isolation and Characterization of a Bacteriophage with Potential for the Control of Multidrug-Resistant Strains Encoding Virulence Factors Associated with the Promotion of Precancerous Lesions.

Amarillas L, Padilla-Lafarga F, Leon Chan R, Padilla J, Lugo-Melchor Y, Lopez Avendano J Viruses. 2024; 16(11).

PMID: 39599826 PMC: 11598880. DOI: 10.3390/v16111711.


Molecular and clinical epidemiology of carbapenem resistant , and Enterobacterales in Fiji: a multicentre prospective observational study.

Baleivanualala S, Matanitobua S, Soqo V, Smita S, Limaono J, Sharma S Lancet Reg Health West Pac. 2024; 47:101095.

PMID: 38867891 PMC: 11166881. DOI: 10.1016/j.lanwpc.2024.101095.


The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019-2022.

Getahun Strobel A, Prasad P, Lane C, Naidu R, Autar S, Young-Sharma T Lancet Reg Health West Pac. 2024; 45:101036.

PMID: 38516290 PMC: 10955629. DOI: 10.1016/j.lanwpc.2024.101036.


Development of a cross-sectoral antimicrobial resistance capability assessment framework.

Ferdinand A, McEwan C, Lin C, Betham K, Kandan K, Tamolsaian G BMJ Glob Health. 2024; 9(1).

PMID: 38232993 PMC: 10806917. DOI: 10.1136/bmjgh-2023-013280.


References
1.
Mendelson M, Matsoso M . The World Health Organization Global Action Plan for antimicrobial resistance. S Afr Med J. 2015; 105(5):325. DOI: 10.7196/samj.9644. View

2.
Gupta V, Ye G, Olesky M, Lawrence K, Murray J, Yu K . National prevalence estimates for resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States. Int J Infect Dis. 2019; 85:203-211. DOI: 10.1016/j.ijid.2019.06.017. View

3.
. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View

4.
Drieux L, Brossier F, Sougakoff W, Jarlier V . Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2007; 14 Suppl 1:90-103. DOI: 10.1111/j.1469-0691.2007.01846.x. View

5.
Iskandar K, Molinier L, Hallit S, Sartelli M, Hardcastle T, Haque M . Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Antimicrob Resist Infect Control. 2021; 10(1):63. PMC: 8011122. DOI: 10.1186/s13756-021-00931-w. View